cart

0.00
HPLC testedCOA every batchEU shippingSEPA · secure paymentResearch Use Only
PEPTIQA BIOTECHCJC-1295 (with DAC)5 mgPurity 8% · RUO

Excellent

Rating 4.8 / 5 — early quality score

Peptiqa Reviews

Early quality score — buyers can leave a review after verified purchase.

CJC-1295 (with DAC)

5 mg8% purityLot #CJC129-2026-001

SKU of selected dimension: PEP-CJC-DAC-5MG

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic growth hormone-releasing hormone (GHRH) analogue composed of 30 amino acids. Through the addition of the DAC modification, the peptide is able to form a covalent bond with circulating serum albumin, dramatically prolonging its activity. While natural GHRH remains active only for minutes, CJC-1295 with DAC exhibits a biological half-life of approximately 6–8 days. This extended duration supports continuous activation of growth hormone-releasing hormone receptors (GHRHR) in the anterior pituitary, resulting in prolonged growth hormone secretion and elevated IGF-1 levels. Due to its ability to maintain stable GH activity over extended periods, it has become an important focus of research involving tissue regeneration, body composition, and anabolic signaling.
€112.24incl. VAT
In Stock (40)

Volume pricing

QuantityUnit priceSavings
1 vial112.24
3 vials (−7%)104.92−7%
5 vials (−12%)98.82−12%
Purchase & earn 92 points!

Ratings & reviews

Log in to rate this product after your order arrives. login

Certificate of Analysis

Lab Verified
View certificate before purchase — transparency guaranteed
Research Profile

CJC-1295 (with DAC)scientific profile

Content is for educational and research purposes. Research Use Only.

  • CJC-1295 with DAC (Drug Affinity Complex) is a synthetic growth hormone-releasing hormone (GHRH) analogue composed of 30 amino acids. Through the addition of the DAC modification, the peptide is able to form a covalent bond with circulating serum albumin, dramatically prolonging its activity. While natural GHRH remains active only for minutes, CJC-1295 with DAC exhibits a biological half-life of approximately 6–8 days. This extended duration supports continuous activation of growth hormone-releasing hormone receptors (GHRHR) in the anterior pituitary, resulting in prolonged growth hormone secretion and elevated IGF-1 levels. Due to its ability to maintain stable GH activity over extended periods, it has become an important focus of research involving tissue regeneration, body composition, and anabolic signaling.

More from GH peptidi

This site uses cookies

Accept